番茄社区

Meeting Coverage >

SABCS

T-DM1: A New Adjuvant Standard in High-Risk HER2+ Breast Ca?

Substantial improvements in survival outcomes in KATHERINE trial

SABCS: Translational Before It Was Cool

Growing, evolving while adhering to founding principles

At SABCS, Patient Advocates Take the Stage

Advocates play increasingly important role in breast cancer research

Arimidex: Top Drug for Breast Ca Prevention?

SAN ANTONIO -- Should anastrozole (Arimidex) be the first choice in pharmacologic primary prevention of breast cancer, based on IBIS-II trial results presented here? No, said most experts.

Metformin Role in Breast Cancer Still Unclear

SAN ANTONIO -- Clinical trials of the diabetes drug metformin in breast cancer yielded a few possible clues to anticancer activity but little else, according to a series of reports.

Effexor May Not Mix with Tamoxifen

SAN ANTONIO -- The antidepressant venlafaxine (Effexor), often given to breast cancer patients to treat the hot flashes associated with tamoxifen therapy, might reduce the effectiveness of the drug, a researcher said here.

Statins May Slow Inflammatory Breast Cancer

SAN ANTONIO -- Inflammatory breast cancer grew significantly more slowly in women who had a history of treatment with statin drugs, findings from a large retrospective review showed.

SABCS: Testosterone Relieves Atrophic Vaginitis in Breast Cancer Patients

SAN ANTONIO -- Intravaginal testosterone may offer relief from atrophic vaginitis without the risks of estrogen to breast cancer patients taking aromatase inhibitors, according to a pilot study.